Delivery Order SPE2DB24D2012-SPE2DB25FBXBP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 180 tablets of Sacubitril-Valsartan 97-103 mg, with a contract ceiling value of $1,066.02. This is a firm fixed-price delivery order with an award date of September 5, 2025, and ultimate completion date of September 8, 2025. The contract was competitively awarded without set-aside designation, and performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.25 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 24-26 mg tablets (60-count supply) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $4,589.05 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (180-count). The contract, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by September 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,597.63 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 49-51 mg tablets (60-count supply) on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $3,207.60 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count supply). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 11, 2025, and performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,160.00 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 97-103 mg tablets (60-count units) on August 7, 2025, with completion expected by August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery supporting federal medical...
- The Defense Logistics Agency awarded a $44,508.93 delivery order to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 49-51 mg tablets (180-count supply) under a firm fixed price contract structure. The award was issued on September 5, 2025, with an ultimate completion date of September 8, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,741.44 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg in quantities of 60 tablets. This competitively awarded, firm fixed-price delivery order was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,166.08 for Sacubitril-Valsartan 97-103 mg tablets (60-count) on September 22, 2025, with completion scheduled for September 23, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Sacubitril-Valsartan 97-103 mg in 60-count quantities, valued at $3,128.66 with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical procurement...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBXBPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,966.31 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 97-103 mg tablets (60-count unit) on September 29, 2025, with completion scheduled for September 30, 2025. This is a firm fixed-price, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The contract contains no set-aside designation and represents performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier for federal medical procurement across the military and veterans healthcare systems. As the prime contractor on the DLA Troop Support Medical IDC, the company delivers a comprehensive range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialized medical commodities—to support military healthcare programs globally. This delivery order for Sacubitril-Valsartan, a combination medication used to treat heart failure and hypertension, exemplifies the company's role in fulfilling ongoing pharmaceutical supply needs across the Defense Health Agency and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/29/25 |